Isfort S, Manz K, Teichmann LL, Crysandt M, et al. Step-in dosing of bosutinib in pts with chronic phase chronic myeloid leukemia (CML) after second-generation tyrosine kinase inhibitor (TKI) therapy: results of the Bosutinib Dose Optimization (BODO) Study. Ann Hematol 2023 Aug 18. doi: 10.1007/s00277-023-05394.
PMID: 37592092